Mario Leporace | Personalized Medicine | Best Innovation Award

Published on by Top Pharmaceutical

Mario Leporace | Personalized Medicine | Best Innovation Award

Prof. Dr. Mario Leporace, Hospital and University, Italy

Prof. Dr. Mario Leporace is a distinguished Clinical Radiologist at the Department of Nuclear Medicine and Theragnostics, “Mariano Santo” Hospital, Cosenza, Italy. With expertise in oncologic imaging, hybrid and molecular imaging, and cardiovascular radiology, he is renowned for his advanced diagnostic work using X-ray, CT, MRI, PET/CT, and SPECT/CT. He holds a Master’s in Interventional Oncology and has contributed to over 15 peer-reviewed publications. His professional journey spans top institutions in Rome and Cosenza, marking a career dedicated to innovation in radiology and nuclear medicine.

Publication Profile

Scopus

Education

Prof. Dr. Mario Leporace 🎓 is a distinguished expert in interventional oncology and radiology. In 2022, he earned a Master’s Degree in Interventional Oncology from Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, with a thesis on thermal ablation of bone metastases 🔥🦴. From 2001 to 2005, he completed his post-graduate certification in Radiology at the University of Rome “Tor Vergata” 🏥, graduating cum laude with a thesis on hybrid imaging 🧠📸. He also obtained his Degree in Medicine and Surgery from the same university (1995–2001), graduating with top honors and a thesis in vascular imaging 🫀🧬.

Experience

Prof. Dr. Mario Leporace 🩺 has an extensive career in radiology and nuclear medicine, showcasing over two decades of dedicated medical service. Since October 2017, he has been serving in the Department of Nuclear Medicine and Theragnostics at “Mariano Santo” Hospital in Cosenza, Italy ⚛️🏥. From May 2016 to September 2017, he worked at the Department of Radiology, “Annunziata” Hospital 🏨. Earlier, from March 2006 to April 2016, he contributed to the European Hospital in Rome, and concurrently, from November 2005 to April 2016, served at the Aurelia Hospital in Rome 🏛️🔬, strengthening his clinical expertise across institutions.

Research Focus

Prof. Dr. Mario Leporace focuses his research on Thermal Ablation with Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) 🔬🧠. His work bridges medical physics and oncological applications, exploring non-invasive treatments that use focused ultrasound energy to thermally ablate tumors with MRI precision guidance 🎯. This technique offers cutting-edge therapeutic possibilities in fields such as oncology, neurology, and women’s health 🧬💡. Prof. Leporace’s contributions advance both the clinical outcomes and technological innovation of MRgFUS, making him a key figure in image-guided therapy, minimally invasive surgery, and cancer treatment research .

Publication Top Notes

The Thermal Ablation with MRgFUS: From Physics to Oncological Applications

Francesco Ceppa | Precision Medicine | Excellence in Research

Published on by Top Pharmaceutical

Francesco Ceppa | Precision Medicine | Excellence in Research

Dr Francesco Ceppa,Università cattolica del sacro cuore,Italy

Dr. Francesco Ceppa 👨‍⚕️Born on May 15, 1994, in Pescara, Italy 🇮🇹, Dr. Francesco Ceppa is a dedicated medical professional specializing in Emergency Medicine at the prestigious A. Gemelli Hospital, Università Cattolica del Sacro Cuore 🏥. A graduate in Medicine and Surgery 🎓 (2020), he has excelled with advanced certifications like Advanced Life Support (ALS) 🩺. Dr. Ceppa gained invaluable experience as a COVID-19 vaccinator and through clinical roles in emergency medicine and abdominal surgery. Fluent in Italian 🇮🇹 and proficient in English 🌍, he combines excellent interpersonal 🤝, organizational 📋, and technical skills 💻 to advance patient care.

Publication Profile

orcid

 Academic Background

Dr. Francesco Ceppa is a dedicated medical professional who graduated from the Università Cattolica del Sacro Cuore with a degree in Medicine and Surgery, earning an impressive score of 101/110 🎓. His strong academic foundation is complemented by an outstanding high school diploma 📚 and proficiency in English at the C1 level 🌍. In line with his commitment to excellence in healthcare, Dr. Ceppa obtained an Advanced Life Support (ALS) certification in 2022 🩺, equipping him to handle critical medical situations with expertise. His achievements highlight his passion for advancing his skills and making a meaningful impact in the field of medicine. 💡✨

Professional Experience

Dr. Ceppa has showcased exceptional expertise through various impactful roles. 💉 During the COVID-19 pandemic, he actively contributed to public health by participating in antigen testing and vaccination campaigns. 🩺 His journey in Emergency Medicine began with a residency at the renowned Agostino Gemelli University Hospital, highlighting his commitment to critical care and acute medical settings. 🚨 Additionally, Dr. Ceppa has been involved in clinical collaborations with key departments, including surgery and translational medicine, fostering interdisciplinary connections that may pave the way for groundbreaking research. 🔬 His dedication exemplifies a blend of hands-on care and forward-thinking innovation. 🌟

Research Contributions

Dr. Francesco Ceppa is a dedicated medical professional with exceptional expertise in emergency medicine, holding an Advanced Life Support (ALS) certification 🩺. Renowned for his technical proficiency, he is rated “excellent” in utilizing medical equipment and computer systems for efficient healthcare delivery 💻. His outstanding teamwork and organizational skills 🤝 ensure seamless collaboration in research and clinical settings. However, his CV lacks explicit mention of peer-reviewed publications, conference presentations, research grants, or independent projects, as well as specific contributions to advancing medical science or methodologies. Strengthening these areas could further highlight his impact and expertise in the medical field. 📚✨

Claudia Omes | Clinical Trials | Best Researcher Award

Published on by Top Pharmaceutical

Claudia Omes | Clinical Trials | Best Researcher Award

Dr Claudia Omes, Fondazione IRCCS Policlinico San Matteo, Italy

Dr. Claudia Omes is a distinguished biologist specializing in reproductive medicine, embryology, and stem cell research. She holds multiple degrees from the University of Pavia and Milan, including a Ph.D. in Bioengineering and Bioinformatics. Dr. Omes is the Head Biologist and Lab Director at the Center for Reproductive Medicine at Policlinico “San Matteo,” Pavia, and a Contract Professor at the University of Pavia. She has contributed to pioneering research in cryopreservation, semen analysis, and stem cell biology, with multiple publications in top journals. She is an active member of ESHRE and SIERR. 🧬🔬👩‍🔬📚

Publication Profile

Orcid

Qualifications and Certifications

Dr. Claudia Omes is a distinguished expert in bioengineering and bioinformatics, holding a Ph.D. in the field, along with a Postgraduate degree in Microbiology and Virology, both achieved with high honors 🎓. She also holds multiple specialized certifications, including ISO 9001:2008 Certified Auditor in Public Health 🏅 and certifications in clinical embryology and semen analysis 🧬. Her expertise spans across bioengineering, public health, and clinical research, making her a prominent figure in the scientific community. Dr. Omes’ comprehensive academic background and specialized certifications highlight her commitment to advancing healthcare and biotechnology. 🌿💡

Research Experience

Dr. Claudia Omes is the Head Biologist and Lab Director at the Center for Reproductive Medicine of Fondazione I.R.C.C.S. Policlinico “San Matteo.” Her pioneering work in human reproduction and embryology has significantly advanced the field. She specializes in cryopreservation of spermatozoa, oocytes, and embryos, as well as in stem cell research and bone tissue engineering. Through her dedication and expertise, Dr. Omes has made notable contributions to reproductive medicine, with a focus on improving fertility treatments and tissue regeneration. Her work continues to shape the future of reproductive science. 🧬🔬🍼👩‍🔬

Awards and Recognition

Dr. Claudia Omes has earned significant recognition in the scientific community. She was awarded the Best Oral Communication in the Biological Field at the II FISSR conference in Riccione (May 24-26, 2012) 🏅. In 2011, she received the GIC Study Award from the Italian Society of Cytometry at the XXIX National Conference of Cytometry in Salerno 🎖️. Dr. Omes was also honored with the Best Poster award at the 62nd National Congress of SIAI in Verona (September 14-16, 2008) 🎨. These accomplishments showcase her excellence in the fields of cytometry and biological sciences 🌱🔬.

Research Focus

Dr. Claudia Omes focuses on reproductive biology and male infertility, exploring factors that impact sperm quality and fertility. Her research investigates the role of infections, inflammation, and biomarkers in male fertility, particularly in infertile and oncological patients. She has contributed to studies on the effects of HPV infections (HPV-51 and HPV-52) on sperm quality, the expression of miRNAs in pre-implantation embryos, and the potential of novel diagnostic approaches like calprotectin to screen for male infertility risk. Additionally, Dr. Omes has studied the effects of cancer-induced inflammation on semen quality and the application of stem cells in reproductive medicine. 🧬👨‍🔬💉

Publication Top Notes

HPV-51 or HPV-52 Infection Could Impair Sperm Quality in Infertile Patients: A Preliminary Study on Our Experience from North-Western Italy

Expression of miRNA from spent pre-implantation embryos culture media

Human Ovarian Follicular Fluid Mesenchymal Stem Cells Express Osteogenic Markers When Cultured on Bioglass 58S-Coated Titanium Scaffolds

Calprotectin as a novel diagnostic approach to screen male infertility risk: A pilot study

Male fertility preservation: is there a role for cancer-induced inflammation that affects semen quality in oncological patients?

Myeloperoxidase and lactoferrin as possible inflammatory markers of an infertility risk?

Correction: MAGIC-factor 1, a partial agonist of MET, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis (PLoS ONE (2008) 3:9 (e3223) 10.1371/journal.pone.0003223)

 

 

Serefnur Ozturk | Clinical Trials | Women Researcher Award

Published on by Top Pharmaceutical

Serefnur Ozturk | Clinical Trials | Women Researcher Award

Prof Serefnur Ozturk, Selcuk University Faculty of Medicine, Turkey

Prof. Şerefnur Öztürk is a leading expert in Neurology and Neurointensive Care, currently serving as the Head of the Neurology Department at Selcuk University, Turkey. She has held prominent roles including Vice Dean of the Faculty of Medicine (1996-2020) and President of the Turkish Neurological Society (2014-2021). With significant international influence, she contributes to the European Academy of Neurology and World Stroke Organization. She has led pivotal projects and trials in stroke and COVID-19-related neurological care. Prof. Öztürk is an acclaimed researcher with numerous influential publications in neurology.

Publication Profile

scopus

Education

Prof. Serefnur Ozturk has an impressive educational background. She began her medical studies at Ankara University Medical Faculty, where she earned her degree between 1980 and 1987. Her academic journey continued with a prestigious NATO Fellowship at Arizona University’s Stroke Center in 1993, further enhancing her expertise. In 1998, she advanced her knowledge in neurology and intensive care at Pittsburgh University, where she studied in their renowned Neurology and Intensive Care Department. These experiences have shaped Prof. Ozturk into a leading figure in her field. 🏥🎓🧠

Internship and Residencies

Prof. Serefnur Ozturk completed her internship at Ankara University Medical Faculty, where she gained valuable hands-on experience. Following this, she pursued her residency at Ankara Numune Research and Education Hospital, further honing her medical skills. Prof. Ozturk’s dedication to her field is reflected in her board certification, earning the Turkish Neurological Board Council Certificate. This certification recognizes her extensive expertise in neurology, solidifying her status as a trusted professional in her area of specialization. Her journey through internships, residencies, and board certification showcases her commitment to excellence. 🏥💉🧑‍⚕️🧠

Experiences

Prof. Serefnur Ozturk holds numerous prestigious leadership roles in neurology. She served as the President of the Turkish Neurological Society from 2014 to 2021 and is currently a member of various important committees, including the European Academy of Neurology (EAN) COVID-19 Task Force and the World Stroke Organization Global Policy Committee. Additionally, she is the Vice President of the European Environmental Neurology Society and has held positions within the World Federation of Neurology (WFN), including President of the Migrant Neurology Specialty Group. Prof. Ozturk is dedicated to advancing stroke care, cerebrovascular diseases prevention, and diversity in neurology. 🧠🌍👩‍⚕️🏥

Projects

Prof. Serefnur Ozturk has played a pivotal role in several major clinical trials and registries. She is the Principal Investigator of the EAN ENERGY COVID-19 Registry and the ENSEMBLE study, showcasing her leadership in critical research. Additionally, Prof. Ozturk serves as the National Coordinator for the Turkish COVID-19 Registry, the ENOS Trial, and TICH-2. Her expertise extends to key studies like the PERFORM Study (Phase III), FACT (Phase IV), and NAVIGATE-ESUS, where she also holds significant leadership positions. Her contributions to clinical research have greatly impacted neurology and stroke care. 🔬🧠🌍💉

Research Focus

Prof. Şerefnur Öztürk’s research focus lies predominantly in neurology, with a special emphasis on the neurological impacts of COVID-19, ischemic stroke, and innovative prognostic tools like the Selcuk Score. Her work is pivotal in advancing the understanding of how pandemics influence neurological care and the management of post-pandemic risks. Additionally, Prof. Öztürk contributes to cutting-edge stroke prevention and rehabilitation technologies, including web-based solutions. Her contributions drive progress in neuro-COVID research, stroke management, and global neurological health policies, showcasing her commitment to improving outcomes for patients worldwide. 🌍🧠💻

Publication Top Notes

The European Academy of Neurology NeuroCOVID-19 Task Force: A lesson for the future

Muscle mass as a modifier of stress response in acute ischemic stroke patients

Management of patients with neurological diseases considering post-pandemic coronavirus disease 2019 (COVID-19) related risks and dangers — An updated European Academy of Neurology consensus statement

The Effect of Tranexamic Acid on Neurosurgical Intervention in Spontaneous Intracerebral Hematoma: Data from 121 Surgically Treated Participants from the Tranexamic Acid in IntraCerebral Hemorrhage-2 Randomized Controlled Trial

General neurology: Current challenges and future implications

Climate Change and Stroke: A Topical Narrative Review

Prof.Mohamed Abdel-Aziz, Drug Discovery and Development,Best Researcher Award-1133

Published on by Top Pharmaceutical

Prof.Mohamed Abdel-Aziz, Drug Discovery and Development ,Best Researcher Award

Prof.Mohamed Abdel-Aziz, at National Research Centre,Egypt

Author Profile

🎓 Education:

He earned his PhD in Microbiology from Ain Shams University, specializing in Physiological and Genetical Studies on Dextranase Formation by Fungi. His academic journey includes a Master’s degree from Mansoura University and a Bachelor’s degree in Botany.

🔍 Research Focus:

Dr. Abdel-Aziz’s research primarily focuses on Microbial Chemistry, with extensive contributions to understanding microbial enzymes and bioactive compounds.

🌐 International Collaborations:

He has participated in several scientific missions and collaborations worldwide, including Italy, Great Britain, China, Germany, and Sweden, enriching his research with diverse perspectives.

📘 Publications:

Dr. Abdel-Aziz has authored over 145 publications, including original articles, reviews, and books, notably contributing to advancements in microbiology and biotechnology.

🏆 Achievements:

He holds seven patents and has been involved in numerous national and international research projects, enhancing the field’s knowledge and applications.

🌟 Recognition:

With an h-index of 31 and over 3000 citations, his work continues to influence the scientific community globally.

🎓Publication Top Noted:

Paper Title : Effect of plasma superficial treatments on antibacterial functionalization and coloration of cellulosic fabrics

  • Authors: Eid B. M. and Abdel-Aziz M. S. Ibrahim N. A.
  • Journal: Applied Surface Science
  • Year: 2017
Paper Title :Preparation of polystyrene nanocomposites based on silver nanoparticles using marine bacterium for packaging
    • Authors: Ahmed M Youssef, Mohamed S Abdel-Aziz
    • Journal:Polymer-Plastics Technology and Engineering
    • Year: 2013
Paper Title : Seven naphtho-γ-pyrones from the marine-derived fungus Alternaria alternata: structure elucidation and biological properties
  • Authors: Mohamed Shaaban, Khaled A Shaaban, Mohamed S Abdel-Aziz
  • Journal:Organic and medicinal chemistry letters
  • Year: 2012
Paper Title :Seven naphtho-γ-pyrones from the marine-derived fungus Alternaria alternata: structure elucidation and biological properties
  • Authors: Mohamed Shaaban, Khaled A Shaaban, Mohamed S Abdel-Aziz
  • Journal:Organic and medicinal chemistry letters
  • Year: 2012

Paper Title :Design, synthesis and biological investigation of certain pyrazole-3-carboxylic acid derivatives as novel carriers for nitric oxide

  • Authors: El-Shimaa MN Abdel-Hafez, Gamal El-Din AA Abuo-Rahma, Mohamed Abdel-Aziz, Mohamed F Radwan, Hassan H Farag
  • Journal:Bioorganic & medicinal chemistry
  • Year: 2009